Report- COVID-19 Omicron Subvariant Shows Two New Symptoms Individuals should be on the lookout for two new COVID-19 symptoms that have been found in patients suffering with the novel omicron subvariant, BA.2.
Report- COVID-19 Omicron Subvariant Shows Two New Symptoms
Symptoms of the Stealth Omicron
Following a month in which the omicron subvariant BA.2 made headlines for being a “stealth” version of the novel coronavirus, health officials are now warning of the emergence of two new symptoms that are not generally seen in patients infected with other versions of the virus.
According to the Spokane Regional Health District (SRHD), consumers should also look for dizziness and exhaustion while trying to determine whether or not they have contracted the COVID-19 virus, which was announced last week. According to the data that was collected, the symptoms were common in BA.2 instances.
According to prior research, the BA.2 subvariant of SARS-CoV-2 exhibits somewhat different symptoms than the original strain of the virus, and it has also been shown to transmit 30 percent more quickly than the virus’s main variant, omicron.
The BA.2 Subvariant: What You Need to Know
Earlier this month, health specialists reported that stealth omicron contained alterations that were similar to the delta variation rather than the parent variant. As a result, BA.2 is more difficult to distinguish from its predecessor, BA.1, which was an omicron variant.
PCR testing will not be able to distinguish BA.2 from the delta strain due to the similarity of their mutations. The omicron variety, on the other hand, may easily be distinguished from the delta strain using the same test procedure.
Despite the fact that it was given the moniker “stealth omicron,” which implied that it would pose a considerably greater threat than delta, this was not the case. Aside from the fact that the COVID-19 vaccinations do not cause more severe sickness than the delta variation, experts claim that they are just as effective against BA.2 as other strains of the virus.
Taking Care of Stealth Omicron
In recent months, the dramatic increase in COVID-19 cases across the globe has been attributed to the stealth omicron virus. According to AL.com, despite the fact that it has been documented in all 50 states, the disease is not widespread in the United States.
According to Francisco Velazquez, SRHD health officer, it is critical to keep track of symptoms, particularly the two that have recently been reported: dizziness and exhaustion. However, because these symptoms are non-specific and could be caused by a variety of other ailments and diseases, he advised everyone to get vaccinated and boosted in order to reduce the risk of contracting an infection.
The vaccines are also recommended by the Centers for Disease Control and Prevention (CDC) since they are still the most effective weapons against COVID-19 and its variations, the organization says. COVID vaccines are already available to the general public, including children as young as 5 years old, according to the CDC.
It is worth noting that the Centers for Disease Control and Prevention has designated stealth omicron as a variant of concern under its parent variety. According to the researchers, a past infection with the BA.1 strain does not confer protection against the BA.2 strain.